DDC
MLAB icon

DF Dent & Co’s Mesa Laboratories MLAB Stock Holding History

DF Dent & Co’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-54,556
Closed -$5.73M – 262
2023
Q3 		$5.73M Buy
54,556
+258
+0.5% +$33.1K 0.08% 95
2023
Q2 		$6.98M Sell
54,298
-2,396
-4% -$365K 0.09% 90
2023
Q1 		$9.91M Buy
56,694
+5,593
+11% +$1M 0.14% 82
2022
Q4 		$8.49M Sell
51,101
-3,165
-6% -$496K 0.13% 83
2022
Q3 		$7.64M Sell
54,266
-1,203
-2% -$219K 0.12% 84
2022
Q2 		$11.3M Buy
55,469
+4,044
+8% +$885K 0.16% 76
2022
Q1 		$13.1M Sell
51,425
-9,402
-15% -$2.55M 0.15% 76
2021
Q4 		$20M Buy
60,827
+256
+0.4% +$80.4K 0.2% 63
2021
Q3 		$18.3M Buy
60,571
+4,308
+8% +$1.22M 0.19% 66
2021
Q2 		$15.3M Buy
56,263
+3,247
+6% +$824K 0.16% 70
2021
Q1 		$12.9M Buy
53,016
+3,394
+7% +$934K 0.15% 72
2020
Q4 		$14.2M Buy
49,622
+4,009
+9% +$1.1M 0.17% 62
2020
Q3 		$11.6M Buy
45,613
+1,104
+2% +$262K 0.16% 60
2020
Q2 		$9.65M Buy
44,509
+2,517
+6% +$580K 0.15% 63
2020
Q1 		$9.49M Buy
41,992
+1,700
+4% +$419K 0.18% 54
2019
Q4 		$10M Buy
40,292
+540
+1% +$126K 0.17% 54
2019
Q3 		$9.45M Buy
39,752
+13,719
+53% +$3.17M 0.17% 52
2019
Q2 		$6.36M Buy
26,033
+272
+1% +$63.3K 0.12% 68
2019
Q1 		$5.94M Buy
25,761
+18,581
+259% +$4.2M 0.12% 71
2018
Q4 		$1.5M Sell
7,180
-3,507
-33% -$684K 0.04% 113
2018
Q3 		$1.98M Buy
10,687
+2,159
+25% +$435K 0.04% 106
2018
Q2 		$1.8M Sell
8,528
-2,680
-24% -$469K 0.04% 108
2018
Q1 		$1.66M Buy
11,208
+276
+3% +$37.6K 0.04% 107
2017
Q4 		$1.36M Buy
10,932
+396
+4% +$55.4K 0.03% 91
2017
Q3 		$1.57M Buy
10,536
+2,042
+24% +$288K 0.04% 80
2017
Q2 		$1.22M Buy
8,494
+2,346
+38% +$333K 0.03% 82
2017
Q1 		$754K Buy
6,148
+1,867
+44% +$229K 0.02% 93
2016
Q4 		$525K Buy
4,281
+607
+17% +$75.8K 0.01% 121
2016
Q3 		$420K Buy
+3,674
New +$419K 0.01% 118

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

DF Dent & Co's MLAB Position: Q4 2023 in Review

DF Dent & Co sold out of Mesa Laboratories (MLAB) in Q4 2023, closing a stake of 54,556 shares — an estimated $5.73M sold.

DF Dent & Co first reported a position in MLAB in Q3 2016 and held it in 29 quarters. The position peaked at $20M in Q4 2021. 158 funds tracked by Wall St. Rank hold MLAB as of Q4 2023.

  • DF Dent & Co reported no remaining Mesa Laboratories position as of Q4 2023 after selling out during the quarter.
  • DF Dent & Co sold 54,556 Mesa Laboratories shares in Q4 2023, an estimated $5.73M.
  • DF Dent & Co first reported a position in Mesa Laboratories in Q3 2016 and held it in 29 quarters.
  • DF Dent & Co's Mesa Laboratories position peaked at $20M in Q4 2021.
  • 158 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2023.

Based on DF Dent & Co's 13F filing for Q4 2023, filed 14 Feb 2024.